Jones Financial Companies
LUCD icon

Jones Financial Companies’s Lucid Diagnostics LUCD Stock Holding History

Jones Financial Companies’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13K Hold
1,010
– – ﹤0.01% 4319
2025
Q4 		$1.1K Sell
1,010
-100
-9% -$112 ﹤0.01% 3991
2025
Q3 		$1.14K Buy
1,110
+100
+10% +$109 ﹤0.01% 3859
2025
Q2 		$1.18K Hold
1,010
– – ﹤0.01% 3617
2025
Q1 		$1.6K Buy
1,010
+1,000
+10,000% +$1.2K ﹤0.01% 3299
2024
Q4 		$8 Sell
10
-1,906
-99% -$1.68K ﹤0.01% 3406
2024
Q3 		$1.5K Sell
1,916
-1,915
-50% -$1.57K ﹤0.01% 2735
2024
Q2 		$3.14K Hold
3,831
– – ﹤0.01% 2062
2024
Q1 		$3.1K Buy
+3,831
New +$4.97K ﹤0.01% 1227

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Jones Financial Companies's LUCD Position: Q1 2026 in Review

Jones Financial Companies held its Lucid Diagnostics (LUCD) position steady in Q1 2026 at 1,010 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #4319.

Jones Financial Companies first reported a position in LUCD in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.14K in Q2 2024. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Jones Financial Companies held 1,010 shares of Lucid Diagnostics worth $1.13K as of Q1 2026.
  • Jones Financial Companies left its Lucid Diagnostics share count unchanged in Q1 2026.
  • Lucid Diagnostics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4319 holding.
  • Jones Financial Companies first reported a position in Lucid Diagnostics in Q1 2024 and has held it in 9 quarters since.
  • Jones Financial Companies's Lucid Diagnostics position peaked at $3.14K in Q2 2024.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.